The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence
Abstract
BACKGROUND: Buprenorphine is a partial agonist at the mu-opioid receptor that has been proposed as an alternative to traditional full agonist maintenance therapy for the treatment of opioid addiction. We report on a clinical trial in which the relative safety and efficacy of long-term fixed-dose buprenorphine maintenance was examined in comparison to low- and high-dose methadone maintenance. METHODS: Two hundred twenty-five treatment-seeking opioid addicts (46 women, 179 men) were randomly assigned to receive, in a double-blind manner, either 8 mg/d of buprenorphine, 30 mg/d of methadone, or 80 mg/d of methadone maintenance over a 1-year period. Objective and subjective measures of efficacy (urine toxicology, retention, craving, and withdrawal symptoms) were examined at the study midpoint and at termination, and safety data were tabulated over the entire 52-week study period. RESULTS: Patients assigned to high-dose methadone maintenance performed significantly better on measures of retention, opioid use, and opioid craving than either the low-dose methadone or the buprenorphine group at both 26-week and 52-week time points. Performance on these measures was virtually identical between the latter two groups. No serious adverse health effects attributable to buprenorphine were noted. CONCLUSIONS: Buprenorphine maintenance at 8 mg/d appears to be less than optimally efficacious under the conditions of the present study. Continued research is needed to reconcile these findings with the more positive results reported by other investigative groups. There are no apparent health risks associated with long-term buprenorphine maintenance at this dosage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mean 1-year retention in treatment is approximately 60% and can vary based on adherence to evidence-based dosing practices.”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [66]
In the citing paper
“phase III research reports indicate that buprenorphine maintenance is quite safe with equivalent adverse events to methadone and placebo”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [66]
Citations
Cites
McLELLAN, A. T., LUBORSKY, L., WOODY, G. E., & O??BRIEN, C. P. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198001000-00006 · Cited by 3,188
Drug Abuse Treatment: A National Study of Effectiveness
Hubbard, R. L., Marsden, M. E., Rachal, J. V., Harwood, H. J., Cavanaugh, E. R., & Ginzburg, H. M. (1989) · Medical Entomology and Zoology · Cited by 1,028
The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services, and Outcome
Ball, J. C., & Ross, A. O. (1991) · Cited by 903
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782 · cited 1×
“The potential utility of buprenorphine for the treatment of opioid addiction was apparent in the definitive work of Jasinski et al, [18] who demonstrated that daily dosages of 8 mg sublingually blocked the effects of subsequently administered morphine and did not appear to induce significant physical dependence.”
BackgroundThe Effectiveness of Methadone Maintenance Treatment
Ball, J. C., & Ross, A. (1991) · Springer eBooks · doi:10.1007/978-1-4613-9089-3 · Cited by 590 · cited 1×
“[1-7] Further, methadone maintenance therapy for opioid addiction has been shown to decrease the mortality and morbidity associated with illicit drug use, [1,8,9] dramatically diminish the transfer of the human immunodeficiency virus, [10-12] profoundly reduce criminal activity, [13-15] and normalize disruptions in im…”
BackgroundA Controlled Trial of Buprenorphine Treatment for Opioid Dependence
Johnson, R. E. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480200058024 · Cited by 572 · cited 3×
“[25] That study evaluated outcomes in 162 patients during 17 weeks of maintenance treatment and concluded that 8 mg/d of buprenorphine was as effective as 60”
BackgroundMethodResultTreatment for Drug Abuse: Follow-up Outcomes and Length of Time Spent
Simpson, D. D. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780330033003 · Cited by 388 · cited 1×
“[1-7] Further, methadone maintenance therapy for opioid addiction has been shown to decrease the mortality and morbidity associated with illicit drug use, [1,8,9] dramatically diminish the transfer of the human immunodeficiency virus, [10-12] profoundly reduce criminal activity, [13-15] and normalize disruptions in im…”
BackgroundBuprenorphine suppresses heroin use by heroin addicts
Mello, N. K., & Mendelson, J. H. (1980) · Science · doi:10.1126/science.7352279 · Cited by 298
Buprenorphine versus Methadone Maintenance for Opioid Dependence
KOSTEN, T. R., SCHOTTENFELD, R., ZIEDONIS, D., & FALCIONI, J. (1993) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199306000-00004 · Cited by 267 · cited 1×
“Several controlled clinical trials comparing the effectiveness of buprenorphine and methadone in maintenance treatment have been published [25,26] or are currently in some stage of completion.”
BackgroundRisk Reduction for the Acquired Immunodeficiency Syndrome Among Intravenous Drug Users
JARLAIS, D. C. D., FRIEDMAN, S. R., & HOPKINS, W. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-5-755 · Cited by 252 · cited 1×
“[1-7] Further, methadone maintenance therapy for opioid addiction has been shown to decrease the mortality and morbidity associated with illicit drug use, [1,8,9] dramatically diminish the transfer of the human immunodeficiency virus, [10-12] profoundly reduce criminal activity, [13-15] and normalize disruptions in im…”
Background
Cited by
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005359 · Cited by 986
“Obstetrical problems 29 (33) 23 (27) 3 (4) 4 (7)”
InfluentialUnderstanding polydrug use: review of heroin and cocaine co‐use
Leri, F., Bruneau, J., & Stewart, J. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00236.x · Cited by 790
Linehan, M. M., Dimeff, L. A., Reynolds, S. K., Comtois, K. A., Welch, S. S., Heagerty, P., & Kivlahan, D. R. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00011-x · Cited by 741
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Metadata
- Authors
- Ling, W.
- Corresponding author
- Ling, Walter
- ORCID
- Ling, Walter
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1996-05-01
- Volume
- 53
- Issue
- 5
- Pages
- 401
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W1980315117
- Cited by
- 366
- References
- 20
- Citations by year
- 2025: 3 · 2024: 4 · 2023: 5 · 2022: 7 · 2021: 6 · 2020: 5 · 2019: 4 · 2018: 3 · 2017: 6 · 2016: 9 · 2015: 9 · 2014: 12 · 2013: 12 · 2012: 18
- FWCI
- 16.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r18da006082-05)
- National Institute on Drug Abuse (R18 DA6082)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- buprenorphine, methadone maintenance treatment, opioid use disorder, opioid dependence treatment, treatment retention, opioid craving, withdrawal symptoms, drug use, treatment efficacy, drug safety, dose comparison
- MeSH terms
- Adult, Buprenorphine, Cocaine, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Heroin Dependence, Humans, Male, Methadone, Opioid-Related Disorders, Placebos, Substance Abuse Detection, Treatment Outcome, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence. https://app.cochat.ai/papers/10.1001/archpsyc.1996.01830050035005
- The paper
- Ling, W. (1996). A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1996.01830050035005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.